ARCHIVES

Contract Proposal Would Assess Outcomes Other Than Incidence, Response, Mortality

This article is from The Cancer Letter archive.

Vol. 13 No. 36 | September 18, 1987

Download PDF Visit The Full Archive

Related Articles

EntreMed Begins Phase I/II Trial For Endostatin.

July 27, 2001

Patient Accrual Up More Than 20% This Year Despite Lack Of Significant New Money For Group

November 18, 1988

Also in this issue: ODAC Votes To Strip Breast Cancer Indication From Avastin

July 23, 2010

FDA News< Regulations To Ease For Advertising Drugs On TV, Radio

September 12, 1997

UCSF Wins $500,000 Grant From Bristol-Myers Squibb Foundation

March 15, 2002

Contracts Awarded For $30 Million Heavy Smokers Clinical Trials

October 10, 1986